Use case and buyer fit
Clarify the healthcare problem the digital offer addresses and which organisations or stakeholder groups are relevant. Prioritise specific use cases over a broad claim of applicability across healthcare.
Healthcare commercial advisory
Digital Health Market Entry UK
Avezda supports digital health teams preparing a commercial route into UK healthcare. We help position digital products and AI-enabled services, identify relevant NHS and independent-sector buyers, and shape the materials and partnerships needed for market entry.
Who we help
For digital health teams preparing buyer engagement
A digital product can be difficult to assess when its commercial proposition is expressed mainly through features. Healthcare buyers also need to understand the use case, intended service context and the evidence available to support the proposed value.
This work focuses on the move from a developed proposition to a practical market entry plan. It brings buyer priorities, procurement considerations and potential delivery partners into the commercial discussion.
How Avezda helps
Focused commercial support
Evidence and procurement narratives
Organise existing evidence and product information into a clearer buyer-facing story. Identify gaps in the commercial materials without presenting intended benefits as measured results.
Entry routes and partnerships
Map possible NHS and private-healthcare routes alongside relevant technology or service partners. Consider the stakeholder engagement and procurement preparation needed for each route.
Our approach
Make the proposition easier to assess
Avezda can work with the team to review the product proposition, intended users, current materials and commercial priorities. This establishes a basis for buyer mapping, market access planning and a more focused engagement narrative.
Potential deliverables include positioning recommendations, a prioritised stakeholder map, procurement-facing materials and a partnership or launch plan. Where entry depends on a specific opportunity, the next step is to assess its requirements and the team's readiness.
Commercial positioning does not replace product validation or establish buyer acceptance. Proposed benefits should remain distinct from evidence already available, and procurement decisions rest with the buyer.
Related expertise
The wider commercial picture
See our broader MedTech & Digital Health advisory. Explore MedTech consultancy for medical-technology commercialisation and NHS market access consultancy for wider entry-route planning.
Talk to Avezda
Preparing a digital health proposition for UK buyers?
Discuss your use case, current stage and the commercial route you need to clarify.